ProCE Banner Activity

A Closer Look at RA Treatment: JAK Inhibitor Efficacy and Safety

Podcast Episodes
Expert faculty Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss the latest data on JAK inhibitors in bDMARD-IR, MTX-IR, and MTX naïve patients with RA.

Released: December 11, 2020

Expiration: December 10, 2021

Share

Faculty

Stanley B. Cohen

Stanley B. Cohen, MD

Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Dallas, Texas

Sheetal Desai

Sheetal Desai, MD, MSEd

Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Eric M. Ruderman

Eric M. Ruderman, MD

Professor
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Faculty Disclosure

Primary Author

Stanley B. Cohen, MD

Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Dallas, Texas

Sheetal Desai, MD, MSEd

Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Eric M. Ruderman, MD

Professor
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois